login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
UNITED THERAPEUTICS CORP (UTHR) Stock News
NASDAQ:UTHR - Nasdaq -
US91307C1027
-
Common Stock
- Currency: USD
299.325
+1.19 (+0.4%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
UTHR Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Chartmill
UNITED THERAPEUTICS CORP (NASDAQ:UTHR): A Prime Value Pick with Strong Fundamentals and Undervalued Potential
20 days ago - By: Chartmill
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) – A Strong Candidate for GARP Investors
2 hours ago - By: Benzinga
Preview: United Therapeutics's Earnings
5 days ago - By: Investor's Business Daily
- Mentions:
INSM
LQDA
Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work?
11 days ago - By: Yahoo Finance
- Mentions:
MS
Morgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating
13 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
14 days ago - By: Yahoo Finance
- Mentions:
LQDA
Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling
19 days ago - By: Yahoo Finance
- Mentions:
UBS
UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR)
22 days ago - By: Zacks Investment Research
- Mentions:
MCK
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
25 days ago - By: Zacks Investment Research
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
a month ago - By: Benzinga
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (9 Ratings)
a month ago - By: United Therapeutics Corporation
United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver
a month ago - By: United Therapeutics Corporation
United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
2 months ago - By: Yahoo Finance
- Mentions:
INSM
WFC
AXSM
EH
...
Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)
2 months ago - By: Yahoo Finance
- Mentions:
SMMT
STLD
OKLO
CCJ
...
Why Summit Therapeutics Stock Tanked Today
2 months ago - By: Investor's Business Daily
- Mentions:
RY
RY.CA
PFE
INSM
...
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
2 months ago - By: Yahoo Finance
- Mentions:
NFLX
SPOT
FOXA
PARA
Prediction: This Tariff-Resistant Growth Stock Could Join the Trillion-Dollar Club by 2030
2 months ago - By: Yahoo Finance
- Mentions:
CRCL
TSLA
SCHW
Is This New Crypto Stock a Potential Millionaire-Maker?
2 months ago - By: Zacks Investment Research
- Mentions:
CPRX
Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?
2 months ago - By: Zacks Investment Research
- Mentions:
CORT
Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound?
Please enable JavaScript to continue using this application.